XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

There were 5,673,861 options outstanding as of March 31, 2021. The fair value of each stock option granted was estimated using the Black-Scholes assumptions and or factors as follows:

 

Exercise price   $ 5.60  
Expected dividend yield     0 %
Risk free interest rate     0.81%-1.54 %  
Expected life in years     5-10  
Expected volatility     149%-158 %  

 

There were 5,597,861 options outstanding as of December 31, 2020. The fair value of each stock option granted was estimated using the Black-Scholes assumptions and or factors as follows:

 

Exercise price   $ 1.75  
Expected dividend yield     0 %
Risk free interest rate     0.64%-1.61 %  
Expected life in years     10  
Expected volatility     140%-146 %  
Schedule of Share-based Compensation, Stock Options, Activity

The following is an analysis of the stock option grant activity under the Plan:

 

         

Weighted

Average

   

Weighted

Average

 
    Number     Exercise Price     Remaining Life  
Stock Options                        
                         
Outstanding December 31, 2020     5,597,861     $ 1.47       6.48  
Granted     366,000     $ 5.60       9.69  
Expired     (280,000 )   $ 1.00       -  
Exercised     (10,000 )   $ 1.00       -  
Outstanding March 31, 2021     5,673,861     $ 1.76       6.78  
Schedule of Share-based Compensation Nonvested Shares

A summary of the status of the Company’s nonvested options as of March 31, 2021, and changes during the three months ended March 31, 2021, is presented below:

 

Nonvested Options   Options    

Weighted-

Average
Exercise Price

 
Nonvested at December 31, 2020     862,833     $ 1.75  
Granted     366,000     $ 5.60  
Vested     (106,291 )   $ 4.70  
Forfeited     -     $ -  
Nonvested at March 31, 2021     1,122,542     $ 2.93  
Summary of Warrant Issuances

A summary of warrant issuances are as follows:

 

         

Weighted

Average

   

Weighted

Average

 
    Number     Exercise Price     Remaining Life  
Warrants                        
                         
Outstanding December 31, 2020     4,007,058     $ 1.06       1.86  
Expired     (150,249 )     1.25       -  
Exercised     (373,042 )     1.25       -  
Outstanding March 31, 2021     3,483,767     $ 1.03       1.85